New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2013
05:47 EDTWLTWalter Energy cites 'serious omissions' in Audley Capital proxy statement
Walter Energy issued a letter to its shareholders raising serious concerns about Audley Capital's slate of nominees and highlighting the steps underway by the company's board and new management team to increase shareholder value. The letter from Chairman Michael T. Tokarz and CEO and Director Walter J. Scheller III highlights "troubling aspects" about Audley's campaign to replace five of its nine independent directors, including the fact that Audley's proxy statement contains serious omissions regarding the background and history of its nominees. These omissions include insider trading charges, deficient governance, and misrepresentations of experience. Walter Energy said the board's nominating and corporate governance committee reviewed the Audley slate and determined that individually and collectively they lack the qualifications and experience to be suitable board candidates. Walter Energy has a balanced mix of experience and expertise on its board, and four of the 10 current directors have joined within the past two years.
News For WLT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 17, 2015
09:20 EDTWLTOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Vipshop Holdings (VIPS), up 10.9%... VASCO Data Security (VDSI), up 7.1%... Waste Management (WM), up 3.7%. ALSO HIGHER: Starwood Hotels (HOT), up 1.9% after appointing Adam Aron as interim CEO... Sarepta Therapeutics (SRPT), up 7.3% after being upgraded at BofA/Merrill... Navidea Biopharmaceuticals (NAVB), up 7.5% after publishing results of phase 3 Lymphoseek trial... Campus Crest (CCG), up 7.7% after announcing that it will explore strategic alternatives as well as Clinton Group and Campus Evolution proxy contest... Cyren (CYRN), up 7.1% following distribution agreement with ALSO Deutschland. DOWN AFTER EARNINGS: Helix Energy (HLX), down 13.3%... Walter Energy (WLT), down 10.1%. ALSO LOWER: Celsus Therapeutics (CLTX), down 82.3% after MRX-6 Cream 2% Phase II trial did not meet primary endpoint... Vascular Biogenics (VBLT), down 53.2% after reporting that VB-201 Phase 2 studies did not meet primary endpoints and removal of FDA partial clinical hold on VB-111... Vanguard Natural Resources (VNR), down 7.1% after reporting preliminary fourth quarter results.
07:38 EDTWLTWalter Energy expects met coal sales 8.5 MMT-9.0 MMT
Walter Energy expects met coal sales to total 8.5 to 9.0 MMTs in 2015. Capital expenditures in 2015 are expected to be in line with 2014, and the company expects to further reduce SG&A expenses by 10%. Cash interest expense is expected to approximate $265M for the year.
07:36 EDTWLTWalter Energy reports Q4 adjusted EPS ($1.97), consensus ($1.59)
Reports Q4 revenue $285.56M, consensus $326.55M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use